The U.S. FDA has granted Regenerative Medicine Advanced Therapy designation to KB707 for the treatment of advanced/metastatic ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

Krystal Biotech (KRYS) stock gains as the company wins FDA RMAT designation for its lung cancer therapy KB707. Read more here ...

Researchers have mapped lung cancer "neighborhoods", finding that cell metabolism is key for determining immunotherapy ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope. Exciting new research presented at the American Society of Clinical Oncology (ASCO) 2025 conference is ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

Chemotherapy and radiation are common treatments for lung cancer. However, immunotherapy may be able to help double a patient's survival, according to a new report. Researchers from New York ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

A meta-analysis of more than 20 phase 3 trials found no clear survival differences by sex or age in metastatic NSCLC but ...

The medication is really taking care of business. A pair of new Canadian clinical trials show poop pills can reduce the toxic ...